Figure 2 — CDK16 as a potential prognostic biomarker correlated with an immunosuppressive tumor microenvironment and benefits in enhancing the effectiveness of immunotherapy in human cancers

Research Paper|Volume 16, Issue 2|pp. 1879–1896

CDK16 as a potential prognostic biomarker correlated with an immunosuppressive tumor microenvironment and benefits in enhancing the effectiveness of immunotherapy in human cancers

Back to articleFigure 2(2 of 11)

100%

Figure 2.Expression of CDK16 in paired tumor and adjacent normal tissues. (A–P) CDK16 expression in paired tumor and adjacent normal tissues from TCGA in indicated tumor types. ^*P < 0.05, ^**P < 0.01, ^***P < 0.001, ^****P < 0.0001.